Behavioral and hormonal effects of centrally injected 'anxiogenic' neuropeptides in growing pigs

Pharmacology Biochemistry and Behavior

Volumn 65, Issue 1, 2000, Pages 123-129

  Parrott, R F ^a   Vellucci, S V ^a   Goode, J A ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

Anxiety Peptide; Behavior; Central Injection; Cortisol; CRH; Pigs; Urocortin

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; GROWTH HORMONE; HYDROCORTISONE; OCTADECANEUROPEPTIDE; PROLACTIN; UROCORTIN;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; EMOTION; GROWTH HORMONE RELEASE; HYDROCORTISONE RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; SWINE;

ANIMALS; ANXIETY; BRAIN; CORTICOTROPIN-RELEASING HORMONE; DIAZEPAM BINDING INHIBITOR; GROWTH HORMONE; HYDROCORTISONE; INJECTIONS, INTRAVENTRICULAR; NEUROPEPTIDES; PEPTIDE FRAGMENTS; PROLACTIN; RECEPTORS, GABA-A; SWINE;

ANIMALIA; RODENTIA; SUIDAE; SUS SCROFA;

EID: 0033965162     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00134-3     Document Type: Article

References (45)

1. Arborelius L., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 160:1998;1-12.
2. Asaba K., Makino S., Hashimoto K. Effect of urocortin on ACTH secretion from rat anterior pituitary in vitro and in vivo. Comparison with corticotropin-releasing hormone Brain Res. 806:1998;95-103.
3. Chalmers D.T., Lovenberg T.W., Grigoriadis D.E., Behan D.P., de Souza E.B. Corticotrophin-releasing factor receptors. From molecular biology to drug design Trend Pharmacol. Sci. 17:1996;166-172.
4. Clement Y., Chapouthier G. Biological bases of anxiety. Neurosci. Biobehav. Rev. 22:1998;623-633.
5. Costa E., Guidotti A. Diazepam binding inhibitor (DBI). A peptide with multiple biological actions Life Sci. 49:1991;325-344.
6. Cronin M.T., Siegel B.J., Moberg G.P. Effects of behavioural stress on plasma levels of growth hormone in sheep. Physiol. Behav. 26:1991;887-890.
7. Dantzer R. Antipunishment effects of diazepam. Interaction with shock and food deprivation levels in pigs Psychopharmacology (Berlin). 58:1978;99-104.
8. Dantzer R., Baldwin B.A. Effects of chlordiazepoxide on heart rate and behavioural suppression in pigs subjected to operant conditioning procedures. Psychopharmacologia. 37:1974;169-177.
9. Dauncey M.J., Buttle H.L. Differences in growth hormone and prolactin secretion associated with environmental temperature and energy intake. Horm. Metab. Res. 22:1990;524-525.
10. De Boer S.F., Katz J.L., Valentino R.J. Common mechanism underlying the proconflict effect of corticotropin-releasing factor, a benzodiazepine inverse agonist and electric foot shock. J. Pharmacol. Exp. Ther. 262:1992;335-342.
11. Donaldson C., Sutton S.W., Perrin M.H., Corrigan A.Z., Lewis K.A., Rivier J.E., Vaughan J.M., Vale W.W. Cloning and characterization of human urocortin. Endocrinology. 137:1996;2167-2170.
12. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration. Is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15:1990;71-100.
13. Ebenezer I.S., Vellucci S.V., Parrott R.F. The effects of the benzodiazepine inverse agonist ethyl-beta-carboline-3-carboxylate (βCCE) on food and water intake in pigs. Br. J. Pharmacol. 120:1997;226p.
14. Farmer C., Dubreuil P., Couture Y., Brazeau P., Petitclerc D. Hormonal changes following an acute stress in control and somatostatin-immunized pigs. Dom. Anim. Endocrinol. 8:1991;527-536.
15. Ferrarese C., Appellonio I., Biachi G., Frigo M., Mazorati C., Pecora N., Perego M., Pierpaoli C., Frattola L. Benzodiazepine receptors and diazepam binding inhibitor. A possible link between stress, anxiety and the immune system Psychoneuroendocrinology. 18:1993;1-22.
16. Ferrero P., Guidotti A., Conti-Tranconi B., Costa E. A brain octadecaneuropeptide generated by tryptic digestion of DBI (diazepam binding inhibitor) functions as a proconflict ligand of benzodiazepine recognition site. Neuropharmacology. 23:1984;1359-1362.
17. Ferrero P., Santi M.R., Conte-Tranconi B., Costa E., Guidotti A. Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI). Biological activity and presence in rat brain Proc. Natl. Acad. Sci. USA. 83:1986;827-831.
18. A receptors and modulated by exogenous steroids. Neuroscience. 85:1998;537-567.
19. Givalois L., Li S., Pelletier G. Role of glucocorticoids in the modulation of corticotropin-releasing hormone mRNA level by the endogenous benzodiazepine receptor ligand octadecaneuropeptide in rat brain. Neuroendocrinology. 68:1998;98-104.
20. Guidotti A., Forchetti C.M., Corda M.G., Konkel D., Bennett C.D., Costa E. Isolation, characterization, and purification to homogenates of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc. Natl. Acad. Sci. USA. 80:1983;3531-3535.
21. Guoth J., Olsen D.B., Kovacs M., Schally A.V. Synthesis, purification and biological evaluation of porcine corticotropin-releasing factor. Life Sci. 41:1987;1003-1010.
22. 2, receptors mediate anxiogenic-like behavior. Regul. Pept. 71:1997;15-21.
23. Johnson R.W., van Borell E.H., Anderson L.L., Kojic L.D., Cunnick J.E. Intracerebroventricular injection of corticotropin-releasing hormone in the pig. Acute effects on behavior, adrenocorticotropin secretion, and immune suppression Endocrinology. 125:1994;642-648.
24. Kakiya S, Yokoi H., Arima H., Iwasaki Y., Oki Y., Oiso Y. Central administration of urocortin inhibits vasopressin release in conscious rats. Neurosci. Lett. 248:1998;144-146.
25. A receptor-mediated postsynaptic potentials in the CA1 region of the rat hippocampus. Br. J. Pharmacol. 125:1998;1529-1542.
26. Mimmack M.L., Parrott R.F., Vellucci S.V. Rapid communication. molecular cloning of the porcine corticotropin-releasing factor gene J. Anim. Sci. 76:1998;2205-2206.
27. Miyabo S., Hisada T., Asato T., Mizushima N., Ueno K. Growth hormone and cortisol responses to psychological stress. Comparison of normal and neurotic subjects J. Clin. Endocrinol. Metab. 42:1976;1158-1162.
28. Moreau J.-L., Kilpatrick G., Jenck F. Urocortin, a novel neuropeptide with anxiogenic-like properties. Neuroreport. 8:1997;1697-1701.
29. Mosuzawa M., Oki Y., Ozawa M., Watanabe F., Yoshimi T. Corticotropin-releasing factor but not urocortin is involved in adrenalectomy-induced adrenocorticotropin release. J. Neuroendocrinol. 11:1999;71-74.
30. Parrott R.F. Central administration of corticotropin releasing factor in the pig. Effects on operant feeding, drinking and plasma cortisol Physiol. Behav. 47:1990;519-524.
31. Parrott R.F. Cortisol release in pigs following peripheral and central administration of ovine and human corticotropin-releasing hormone. Acta Endocrinol. 123:1990;108-112.
32. Parrott R.F. Central effects of CCK ligands in pigs making operant responses for food. Pharmacol. Biochem. Behav. 49:1994;463-469.
33. Parrott R.F., Goode J.A. Effects of intracerebroventricular corticotrophin-releasing hormone and intravenous morphine on cortisol, prolactin and growth hormone secretion in sheep. Dom. Anim. Endocrinol. 9:1992;141-149.
34. B antagonist L365,266 Br. J. Pharmacol. 108:1993;288p.
35. Patthy M., Horvath J., Mason-Garcia M., Szoke B., Schlesinger D.H., Schally A.V. Isolation and amino acid sequence of corticotropin-releasing factor from pig hypothalamus. Proc. Natl. Acad. Sci. USA. 82:1985;8762-8766.
36. Payeur R., Lydiard R.B., Ballenger J.C., Laraia M.T., Fossey M.D., Zealberg J. CSF diazepam-binding inhibitor concentrations in panic disorder. Biol. Psychiatry. 32:1992;712-716.
37. Salak-Johnson J.L., McGlone J.J., Whisnant C.S., Norman R.L., Kraeling R.R. Intracerebroventricular porcine corticotropin-releasing hormone and cortisol effects on immune measures and behavior. Physiol. Behav. 61:1997;15-23.
38. Slobodyansky E., Guidotti A., Wambebe C., Berkovich A., Costa E. Isolation and characterization of a rat brain triakontatetraneuropeptide, a postranslational product of diazepam binding inhibitor. Specific action of the Ro 5-4864 recognition site J. Neurochem. 53:1989;1276-1284.
39. 2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia. Neuroreport. 9:1998;1601-1606.
40. Spiess J., Dautzinberg F.M., Sydow S., Hauger R.L., Rühmann A., Blank T., Radulovic J. Molecular properties of the CRF receptor. Trends Endocrinol. Metab. 9:1998;140-145.
41. Spina M., Merlo-Pich E., Chan R.K.W., Basso A.M., Rivier J., Vale W., Koob G.F. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science. 273:1996;1561-1564.
42. Turnbull A.V., Vaughan J., Revier J.E., Vale W.W., Rivier C. Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat. Endocrinology. 140:1999;71-78.
43. Vaughan T., Donaldson C.B., Hencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Rivier J., Sawchenko P.E., Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin 1 and to corticotropin-releasing factor. Nature. 378:1995;287-292.
44. Vellucci S.V., Parrott R.F. Expression of mRNAs for vasopressin, oxytocin and corticotrophin releasing hormone in the hypothalamus, and of cyclooxygenase-1 and -2 in the cerebral vasculature of endotoxin-challenged pigs. Neuropeptide. 32:1998;439-446.
45. Wang H., Li S., Givalois L., Pelletier G. Influence of adrenal glands on the modulation of prolactin gene expression by the endogenous benzodiazepine ligand octadecaneuropeptide in the male rat pituitary gland. J. Neuroendocrinol. 10:1998;193-198.